All stock lists
Sportradar Group AG (NASDAQ:SRAD)
CH · Delayed Price · Currency is USD
Technology · Software - Application
12.41+0.47 (+3.89%)
Insider Score
––Not scored
SRAD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SRAD analyst forecast
SRAD analyst consensus
Moderate Buy12 ratings
Buy 7 Hold 5 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
SRAD 12-month price target
$22.00+78.5% upsideaverage of 2 firms
$22.00High
$22.00Low
Best analysts covering SRAD
- Benchmark67%success rate · 6 calls
- Citigroup67%success rate · 3 calls
- Needham43%success rate · 14 calls
- Canaccord Genuity40%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SRAD analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Canaccord Genuity | Buy | $22.00 | +83.5% | Reiterated | 2026-10-23 | |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-10-20 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-10-19 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-10-07 |
| Wolfe Research | — | $22.00 | +78.7% | — | 2026-09-02 | |
| — | UBS | Neutral | — | — | Downgraded | 2026-08-05 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-08-04 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-08-04 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-04 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-08-04 |
| — | BTIG | Neutral | — | — | Downgraded | 2026-08-04 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-04 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-08-04 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-04 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2026-08-04 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-04 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-07-23 |
| — | Stifel | Buy | — | — | Reiterated | 2026-07-22 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-07-15 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-07-08 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-06-08 |
| — | Needham | Buy | — | — | Reiterated | 2026-06-08 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-30 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-04-29 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-04-29 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-04-29 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-29 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-29 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-04-29 |
| — | Jefferies | Hold | — | — | Reiterated | 2026-04-29 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-04-29 |
| — | Needham | Buy | — | — | Reiterated | 2026-04-28 |
| — | BTIG | Buy | — | — | Reiterated | 2026-04-28 |
| — | Jefferies | Hold | — | — | Downgraded | 2026-04-24 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-21 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-09 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-04-08 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-03-25 |
| — | Needham | Buy | — | — | Reiterated | 2026-03-04 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-03-04 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-03-04 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-03-04 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-03-04 |
| — | BTIG | Buy | — | — | Reiterated | 2026-03-04 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-01-22 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-01-15 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-01-05 |
| — | UBS | Buy | — | — | Reiterated | 2025-12-09 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-09-19 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-09-03 |
| — | UBS | Buy | — | — | Reiterated | 2025-08-14 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-08-06 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-07-16 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-07-15 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-07-03 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-13 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-12 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-04-16 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-04-16 |
SRAD earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-03 | 0.10 | 0.01 | $434.0M | $433.3M |
| 2026-04-28 | 0.06 | -0.02 | $417.9M | $400.4M |
| 2026-08-03 | 0.07 | -0.01 | $435.9M | $431.5M |
| 2026-11-03 | 0.11 | 0.00 | $405.9M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.